HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Competing interest statement Alert me when this article is cited Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Playford, R J Search for Related Content PubMed PubMed Citation Articles by Playford, R J Topic Collections Relevant Article

New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett’s oesophagus

Correspondence to:
Correspondence to:
Professor R J Playford
Department of Gastroenterology, Imperial College Faculty of Medicine, Hammersmith Hospital, Ducane Rd, London W12 0NN, UK; r.playford@imperial.ac.uk

Keywords: screening; surveillance; cancer; Barrett’s oesophagus

The first 150 words of the full text of this article appear below.

The working party of the BSG has recently produced a document updating recommended guidelines for the management of Barrett’s oesophagus (BO).¹ In this article, the main changes in recommendations are highlighted and their value in the context of the numerous other guidelines and manuscripts that are already available are discussed.

The two key "new" recommendations are

1. BO is defined as an endoscopically apparent area above the oesophagogastric junction that is suggestive of Barrett’s which is supported by the finding of columnar lined oesophagus on histology. The presence of areas of intestinal metaplasia (IM), although often present, is not a requirement for diagnosis.
   
2. For patients with BO but without dysplasia, the recommended surveillance protocols are two yearly, four quadrant biopsies every 2 cm, but jumbo biopsies are not required.
   

Additional recommendations include the advice that endoscopic screening of patients suffering from heartburn in order to detect BO is not . . . [Full text of this article]

Relevant Article

British Society of Gastroenterology guidelines for the diagnosis of Barrett’s oesophagus: are we casting the net too wide?

S J Murphy, B T Johnston, and L J Murray
Gut 2006 55: 1821-1822. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				M. di Pietro, C. J. Peters, and R. C. Fitzgerald Clinical puzzle: Barrett's oesophagus Dis. Model. Mech., July 1, 2008; 1(1): 26 - 31. [Abstract] [Full Text] [PDF]

				C.-J. Yen, J. G. Izzo, D.-F. Lee, S. Guha, Y. Wei, T.-T. Wu, C.-T. Chen, H.-P. Kuo, J.-M. Hsu, H.-L. Sun, et al. Bile Acid Exposure Up-regulates Tuberous Sclerosis Complex 1/Mammalian Target of Rapamycin Pathway in Barrett's-Associated Esophageal Adenocarcinoma Cancer Res., April 15, 2008; 68(8): 2632 - 2640. [Abstract] [Full Text] [PDF]

				S. J. Murphy, A. E. Hughes, C. C. Patterson, L. A. Anderson, R.G.P. Watson, B. T. Johnston, H. Comber, J. McGuigan, J. V. Reynolds, and L. J. Murray A population-based association study of SNPs of GSTP1, MnSOD, GPX2 and Barrett's esophagus and esophageal adenocarcinoma Carcinogenesis, June 1, 2007; 28(6): 1323 - 1328. [Abstract] [Full Text] [PDF]

eLetters: